BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1717828)

  • 1. Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides.
    Glesne DA; Collart FR; Huberman E
    Mol Cell Biol; 1991 Nov; 11(11):5417-25. PubMed ID: 1717828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharomyces cerevisiae transcription elongation mutants are defective in PUR5 induction in response to nucleotide depletion.
    Shaw RJ; Reines D
    Mol Cell Biol; 2000 Oct; 20(20):7427-37. PubMed ID: 11003640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
    Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IMPDH cytoophidium couples metabolism and fetal development in mice.
    Peng M; Keppeke GD; Tsai LK; Chang CC; Liu JL; Sung LY
    Cell Mol Life Sci; 2024 May; 81(1):210. PubMed ID: 38717553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.
    Mortimer SE; Xu D; McGrew D; Hamaguchi N; Lim HC; Bowne SJ; Daiger SP; Hedstrom L
    J Biol Chem; 2008 Dec; 283(52):36354-60. PubMed ID: 18974094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutations in IMPDH2 which cause early-onset neurodevelopmental disorders disrupt enzyme regulation and filament structure.
    O'Neill AG; Burrell AL; Zech M; Elpeleg O; Harel T; Edvardson S; Shaked HM; Rippert AL; Nomakuchi T; Izumi K; Kollman JM
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
    Zaffagni M; Harris JM; Patop IL; Pamudurti NR; Nguyen S; Kadener S
    Elife; 2022 Mar; 11():. PubMed ID: 35293857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression.
    Chong YC; Toh TB; Chan Z; Lin QXX; Thng DKH; Hooi L; Ding Z; Shuen T; Toh HC; Dan YY; Bonney GK; Zhou L; Chow P; Wang Y; Benoukraf T; Chow EK; Han W
    Hepatol Commun; 2020 Sep; 4(9):1362-1381. PubMed ID: 32923839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
    Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
    PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of active RNA polymerase II along the transcribed region is gene-specific and controlled by elongation factors.
    Rodríguez-Gil A; García-Martínez J; Pelechano V; Muñoz-Centeno Mde L; Geli V; Pérez-Ortín JE; Chávez S
    Nucleic Acids Res; 2010 Aug; 38(14):4651-64. PubMed ID: 20385590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
    Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
    J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP dehydrogenase: structure, mechanism, and inhibition.
    Hedstrom L
    Chem Rev; 2009 Jul; 109(7):2903-28. PubMed ID: 19480389
    [No Abstract]   [Full Text] [Related]  

  • 13. Guanylic nucleotide starvation affects Saccharomyces cerevisiae mother-daughter separation and may be a signal for entry into quiescence.
    Sagot I; Schaeffer J; Daignan-Fornier B
    BMC Cell Biol; 2005 May; 6(1):24. PubMed ID: 15869715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo.
    McPhillips CC; Hyle JW; Reines D
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12171-6. PubMed ID: 15292516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice.
    Gu JJ; Tolin AK; Jain J; Huang H; Santiago L; Mitchell BS
    Mol Cell Biol; 2003 Sep; 23(18):6702-12. PubMed ID: 12944494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of trans-dominant modifiers of Prat expression in Drosophila melanogaster.
    Malmanche N; Clark DV
    Genetics; 2003 Aug; 164(4):1419-33. PubMed ID: 12930749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast.
    Hyle JW; Shaw RJ; Reines D
    J Biol Chem; 2003 Aug; 278(31):28470-8. PubMed ID: 12746440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.
    Shaw RJ; Wilson JL; Smith KT; Reines D
    J Biol Chem; 2001 Aug; 276(35):32905-16. PubMed ID: 11441018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence supports a role for the yeast CCR4-NOT complex in transcriptional elongation.
    Denis CL; Chiang YC; Cui Y; Chen J
    Genetics; 2001 Jun; 158(2):627-34. PubMed ID: 11404327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.